15
Participants
Start Date
November 22, 2016
Primary Completion Date
February 25, 2020
Study Completion Date
February 25, 2020
Ceftobiprole medocaril
Ceftobiprole medocaril was administered as a single intravenous infusion, with a bodyweight-adjusted volume, at a constant rate over 4 hours. The ceftobiprole dose was 7.5 mg/kg, which corresponds to 10.0 mg ceftobiprole medocaril.
University of Pittsburgh Medical Center Cancer Center at Magee-Womens Hospital, Pittsburgh
Duke University Hospital, Durham
Norton Children's Hospital, Louisville
Beacon Children's Hospital, South Bend
The University of Texas Health Science Center at Houston, Houston
University of Southern California, Los Angeles
University of California Los Angeles, Los Angeles
Loma Linda University Medical Center, Loma Linda
West Virginia University School of Medicine, Morgantown
UZ Leuven, Leuven
Klinikum der Universität München, Munich
Children Clinical University Hospital, Riga
Vilnius University Children's Hospital, Vilnius
University Children's Hospital of Kraków, Krakow
Lead Sponsor
Basilea Pharmaceutica
INDUSTRY